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Abstract 
 
Metabolic diseases like obesity are a major medical problem and the number of 
affected people is increasing dramatically. It has been shown that chronic 
inflammation mediated by macrophage infiltration during the course of obesity is a 
major hallmark of obesity associated diseases. Also, a variety of adipose tissue 
derived cytokines, adipokines, that modulate inflammation and metabolic 
processes in obesity have been identified in the past years.  Atherosclerosis is one 
of the diseases associated with obesity. The anti-inflammatory cytokine IL-5 is 
expressed in human atherosclerotic lesions as well as in murine atherosclerotic 
lesions. Moreover, it has been shown that atherosclerosis is increased in IL-5-
deficient LDLR-/- mice, demonstrating that IL-5 can act as an atheroprotective 
cytokine. I hypothesized that IL-5 is also expressed in the white adipose tissue, 
because mice on high fat diet exhibit high plasma IL-5 levels. Here, I identified 
stromal vascular cell derived macrophages (F4/80+ SVC) as source of interleukin-
5 in the murine white adipose tissue. Furthermore, I found IL-5 but not IL-5Rα 
mRNA expression to correlate with weight increase in high fat diet fed mice. 
Moreover, pro-inflammatory stimuli such as LPS stimulation of cultured stromal 
vascular cells were found to induce IL-5 protein levels. Finally, genetic deficiencies 
of interleukin-5 resulted in differences in expression of metabolically important 
genes, suggesting a potentially protective function of interleukin-5.  
Thus, my data identify il-5 as an adipose tissue derived cytokine and  suggest that 
interleukin-5 may be added to the list of metabolically important adipokines. 
 
 III 
Kurzfassung 
 
Metabolische Erkrankungen wie Fettleibigkeit sind eines der größten 
medizinischen Probleme und die Anzahl der betroffenen Personen steigt 
dramatisch an. Darüber hinaus wurde gezeigt, dass die chronische Entzündung 
durch Infiltration von Makrophagen in das Fettgewebe während des Verlaufes der 
Fettleibigkeit ein Hauptmerkmal von Fettleibigkeit ist. In den vergangenen Jahren 
wurden viele vom Fettgewebe produzierte Zytokine, sogenannten Adipokine, die 
für die Entzündung und den Stoffwechsel im Fettgewebe verantwortlich sind 
identifiziert. Atherosklerose ist eine Erkrankung die mit Fettleibigkeit in 
Zusammenhang steht. Das entzündungshemmende Zytokine IL-5 ist sowohl in 
atheroskleotischen Läsionen des Menschen als auch der Maus exprimiert. 
Außerdem konnte gezeigt werden, dass Atherosklerose in IL-5/LDLR defizienten 
Mäusen erhöht ist, welches auf eine atheroprotektive Rolle hinweist.  
Die Hypothese ist, dass IL-5 im weißen Fettgewebe exprimiert wird, weil bei 
Mäuse durch fettreiche Diet der IL-5 Spiegel im Plasma ansteigt.  
In meiner Diplomarbeit konnte  ich  Makrophagen, die aus Stromazellen stammen 
(F4/80+ SVC) als Quelle von Interleukin-5 im weißen Fettgewebe der Maus 
nachgewiesen. Des weiteren konnte ich zeigen, dass die mRNA Expression im 
Fettgewebe von IL-5 aber nicht von IL-5Rα mit der Gewichtszunahme von 
Mäusen, die eine fettreiche Diet erhalten haben korreliert. Stimulation von in vitro 
kultivierten Stromazellen des Fettgewebes mit LPS führte zur Induktion von IL-5 
Protein. Schlussendlich, genetische Defizienz von Interleukin-5 in Mäusen 
resultiert in Veränderungen der Expression von wichtigen Genen des 
Stoffwechsels. Dies deutet auf eine potentielle schützende Funktion von 
Interleukin-5 hin. Meine Daten deuten darauf hin, dass Interleukin-5 in die Liste  
der Adipokine aufgenommen werden soll.  
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1. Abbreviations 
 
ACRP30    Adipocyte complement-related protein 30kDa 
Arp3    actin-related protein 3 
β-ME    β-Mercaptoethanol 
BSA    Bovine serum albumin 
Btk    Bruton tyrosin kinase 
cDNA    complementary DNA 
CycB     cyclophilin B 
DNA    Deoxyribonucleic acid 
dNTP    Deoxyribonucleotide triphosphate 
EDTA    Ethylenediaminetetraacetic acid, Titriplex III 
F4/80    Macrophage Marker 
FACS    Fluorescence Activated Cell Sorting 
HPRT    Hypoxanthine-Guanine Phosphoribosyl Transferase 
IL-5     Interleukin-5 
IL-5Rα    Interleukin-5 Receptor α 
JAK    Janus kinase 
M-MLV   Moloney Murine Leukemia Virus  
mRNA    messenger RNA 
PBS    Phosphate Buffered Saline 
RNA    Ribonucleic acid 
RNasin   Ribonuclease Inhibitor 
RPMI-1640   Roswell Park Memorial Institute 1640 
RT    Reverse Transcriptase 
SH2    src homology domain 2 
SH3    src homology domain 3 
SSCS    spleen single-cell suspension 
SVC    stromal-vascular cells 
TAE     Tris-Acetate-EDTA 
Tris    Hydroxymethylaminoethane  
WAT    white adipose tissue 
TBS    Tris buffered saline 
FAF    fatty acid free 
2. Summary  
 
IL-5 has been shown to  act as an atheroprotective cytokine in a mouse model of 
atherosclerosis, because reconstitution of irradiated LDLR -/- mice with bone 
marrow from IL-5 deficient mice led to increased lesion size compared to 
reconstitution with bone marrow from wild-type mice [Binder et al. 2004]. This 
clearly demonstrates the impact of hematopoietic cell derived IL-5 for the 
development of atherosclerotic lesions.  
I tested the hypothesis that adipose tissue may be a major source of secreted IL-5 
during atherogenesis. Adipose tissue is one type of fibrous derived tissue and 
consists of different cell populations like adipocytes and stromal vascular cells 
(SVC). The SVC fraction is composed of preadipocytes, macrophages, endothelial 
cells, mast cells, and other cells. Importantly, obesity has been shown to be 
associated with an increased infiltration of macrophages.  
During my diploma thesis I have established and evaluated a method to separate 
the white adipose tissue into its different compartments. The isolation was done by 
digestion with enzymes and subsequent separation with magnetic beads, which 
are coated with an antibody directed against F4/80 to sort out the macrophages.  
I demonstrate that stromal vascular cells derived macrophages (F4/80+ SVC) 
express interleukin-5 mRNA in the murine gonadal white adipose tissue. 
Furthermore, high fat diets induce the IL-5 mRNA expression in the stromal 
vascular fraction compared to normal diet fed C57BL/6 mice. Interleukin-5 may be 
added to the list of adipokines. 
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3. Introduction 
 
3.1. Metabolic syndromes 
 
The metabolic set of symptoms or in short the metabolic syndrome is 
characterized by a set of metabolic risk factors in humans [American-Heart-
Association 2007]. The metabolic syndrome emerges from defective metabolic 
processes in the body. One prime cause of the metabolic abnormalities is visceral 
obesity, which is characterized by excess fat storage in and around the abdomen 
[Matsuzawa 2006]. Pathologies of the metabolic syndrome are diabetes mellitus 
type 2, high blood pressure, decreased HDL cholesterol, elevated triglycerides and 
cardiovascular diseases (CVD) like atherosclerosis. CVD is the major cause of 
death in industrialized countries. The metabolic syndrome is one of the major 
upcoming medical problems and the number of affected people has dramatically 
increased in the last twenty years worldwide [UT-Southwestern-Medical-Center 
2006]. 
 
3.1.1. Obesity, adipose tissue and inflammation 
 
Obesity is the most common metabolic disease and it is affecting over 50% of the 
adult population [Wellen and Hotamisligil 2003]. Obesity and overweight are 
defined as an accumulation of excess body fat that may impair health. The body 
mass index (BMI) is a simple index that is commonly used in classifying obesity 
and overweight in adult populations and individuals. It is defined as the weight in 
kilograms divided by the square of the height in meters. The World Health 
Organization (WHO) defines "overweight" as a BMI equal to or more than 25, and 
"obesity" as a BMI equal to or more than 30. Obesity does not occur suddenly but 
may arise during life time. Nonetheless, increasing numbers of obese children 
recently have drawn attention of health care organizations. Generally, an 
imbalance between energy intake and energy expenditure is the fundamental 
cause of obesity and overweight [WHO 2006]. 
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The serious health consequences that are associated with obesity increase 
progressively as the BMI increases. Raised body mass index is a major risk factor 
for chronic diseases such as cardiovascular disease, diabetes and some cancers 
(breast and colon) [Reaven 1997; WHO 2006; WHO 2006; American-Heart-
Association 2007; MedlinePlus 2007]. In addition, metabolic and morphological 
alterations in other organs can be observed in obesity, including moderate 
peroxisome proliferator-activated receptors γ (PPARγ) mRNA expression in 
skeletal muscle and lung, fat storage in liver (nonalcoholic fatty liver) or alterations 
in gastrointestinal motility [Moller and Berger 2003; Xing and Chen 2004; Jernas et 
al. 2006; Stienstra et al. 2006].  
 
Adipose tissue is a complex and highly active metabolic endocrine organ. Many 
cytokines, adipokines (= adipose derived cytokines) and other factors, which are 
secreted from the adipose tissue, could be identified: For example: leptin, 
adiponectin, resistin, visfatin, adipsin, interleukin-6, tumor necrosis factor-alpha, 
retinol binding protein 4, and plasminogen activator inhibitor-1 [Hotta and 
Matsuzawa 2001; Steppan and Lazar 2004; Fantuzzi and Mazzone 2007; Lara-
Castro et al. 2007]. The adipose tissue is primarily located under the skin 
(subcutaneous adipose tissue), but also around organs [Kershaw and Flier 2004]. 
Depending on the location one can distinguish different 'adipose depots', for 
example the murine gonadal white adipose retroperitoneal, mesenteric and 
inguinal adipose tissue [Oliver et al. 2003; Danireed 2006]. 
 
The main role of adipose tissue is to store energy in the fat [ScienceDaily 2004]. In 
mammals, two types of adipose tissue exist: white adipose tissue (WAT) and 
brown adipose tissue (BAT), which are also known as white fat and brown fat, 
respectively. Both tissue types are mainly built up by specialized cells, the so 
called adipocytes. Adipocytes of the white adipose tissue contain a large lipid 
droplet surrounded by a ring of cytoplasm and a flattened, crescent-shaped 
nucleus which is located at the periphery [Requena 2007]. Brown adipocytes have 
a higher content of cytoplasm than white adipocytes, with far-scattered lipid 
droplets. The nucleus is round and located centrally. The brown colour derives 
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from the large amount of mitochondria. Unlike white adipose tissue, which stores 
nutrients in form of triglycerides, brown adipose tissue consumes its nutrient stores 
to produce heat to warm the body. Brown adipose tissue is largely reduced in 
adults because the majority of mitochondria are abolished during lifetime [PP 
2004]. Besides mature adipocytes, adult white adipose tissue contains 
preadipocytes, connective tissue, neuronal cells, microvascular endothelial cells 
pluripotent stem cells, and - very importantly - also immune cells such as 
macrophages. Adipose tissue exhibits an organized structure (Figure 1) [Schaffler 
et al. 2005]. 
 
.  
Figure 1: Schematic representation of the white adipose tissue 
[Schaffler et al. 2005] 
 
All cells other than adipocytes in the white adipose tissue are called stromal 
vascular cells (SVC) (Figure 2). The complex signaling among adipocytes and 
cells of the stromal vascular fraction is still not fully understood. 
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Figure 2: White adipose tissue contains two major cellular fractions. Adipocytes 
contain large lipid vesicles. Stromal vascular cell fraction is composed of many 
different cell types, modified [Ahima]. 
 
Preadipocytes have phagocytic capabilities and can trans-differentiate into 
macrophages [Charriere et al. 2003; Weisberg et al. 2003; Xu et al. 2003; Curat et 
al. 2004] but the function of macrophages in the adipose tissue is not described so 
far.  
 
Both cell types, adipocytes and macrophages express common genes, such as 
PPARγ [Lee and Evans 2002] 
Importantly, macrophage accumulation in white adipose tissue has been shown to 
be directly associated with obesity in both, human subjects and mice (Figure 3) 
[Weisberg et al. 2003]. 
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Figure 3: Macrophages in the white adipose tissue of C57BL/6J mice.  
Lean male (A) and Lep-ob/ob male (B) mice. F4/80+ (black arrows) macrophages 
are stained brown. In lean animals (A), F4/80+ cells were small and not often seen 
in aggregates. More F4/80+ cells were observed in the severely obese Lep-ob/ob 
mice (B). In addition, obese animals contained aggregates of F4/80+ cells (large 
blue arrows) and a larger adipocyte cell size. Some macrophage aggregates 
contained small lipid-like droplets (small thin black arrow). Calibration mark = 40 
μm. Modified after [Weisberg et al. 2003] 
  
Adipose tissue derived macrophages of lean mice are typically small and 
distributed over the whole tissue, whereas in obese mice they form aggregates or 
surround adipocytes. The formation of macrophage aggregates in the white 
adipose tissue suggests an affinity for defective or necrotic adipocytes. 
Furthermore, adipose tissue derived macrophages are considered to be the main 
source to promote the low grade inflammation in obesity [Cancello et al. 2006]. 
The recruitment of macrophages during adipose tissue inflammation is partly 
dependent on the glycoprotein osteopontin (OPN), which is a major pro-
inflammatory cytokine and plays amain important role in the cell-mediated 
immunity [Giachelli et al. 1998].  
Activated macrophages secrete high levels of OPN which further leads to 
monocyte recruitment [Giachelli et al. 1998].  
 
Monocyte chemoattractant protein-1 (MCP-1) or CCL2 is another important 
adipokine and is involved in macrophage infiltration of the white adipose tissue 
[Kanda et al. 2006]. 
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3.1.2. Adipokines 
 
White adipose tissue seems to play an active role in immunity and inflammation. A 
variety of pro-inflammatory and anti-inflammatory factors, as well as cytokines and 
chemokines, such as TNF-α, IL-6, monocyte chemoattractant protein 1 (MCP-1), 
and many others are secreted by adipose tissue and are called adipokines  
(Figure 4) [Laimer et al. 2002; Fantuzzi 2005; Trayhurn and Wood 2005].  
 
 
 
Figure 4: Adipose tissue derived chemokines 
 
Proinflammatory molecules produced by adipose tissue have been implicated as 
active participants in the development of insulin resistance and in the increased 
risk of cardiovascular disease associated with obesity [Kershaw and Flier 2004; 
Fantuzzi 2005; Trayhurn and Wood 2005].  
 
Adipokines are involved in many different physiological processes such as 
haemostasis, blood pressure regulation, insulin sensitivity, lipid metabolism and 
angiogenesis [Fruhbeck et al. 2001; Trayhurn and Beattie 2001; Rajala and 
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Scherer 2003; Trayhurn and Wood 2004]. Moreover, during development of 
obesity and the change in adipose tissue mass, there is also a change in the 
composition of secreted adipokines [Weisberg et al. 2003]. The number of 
inflammation associated adipokines increases rapidly which indicates the 
important role of the white adipose tissue.  
 
Inflammation in obesity is characterized by the increased production of 
inflammatory molecules like C-reactive protein (CRP), IL-18, macrophage 
migration inhibitory factor (MIF), monocyte chemoattractant protein-1 (MCP-1) and 
plasminogen activator inhibitor 1 (PAI-1) in the circulation [Trayhurn and Wood 
2004]. High sensitivity measurements of CRP (hsCRP) are a marker for 
inflammation [Laimer et al. 2002; Panagiotakos et al. 2005]. And it has been 
shown that the reduction of body weight is associated with a significantly decrease 
in circulating CRP levels [Laimer et al. 2002; Esposito et al. 2003].  
TNF-α has been shown to be an important mediator of insulin resistance during 
the state of obesity [Peraldi and Spiegelman 1998; Laimer et al. 2002]. 
One exception is the major adipose tissue derived hormone adiponectin which 
decrease during the state obesity and act as an anti-inflammatory molecule [Arita 
et al. 1999; Ouchi et al. 2000] 
The secretion of inflammatory adipokines associated with a high BMI are important 
factors in the development of chronic inflammatory state in obesity [Yudkin 2003] 
The consequences of inflammation in obesity are atherosclerosis, Type II diabetes 
and other metabolic syndrome associated diseases [Trayhurn and Wood 2005]. 
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3.1.1. Atherosclerosis and Atherogenesis 
 
Atherosclerosis is a disease that affects arterial blood vessels. It is a chronic 
inflammatory disease of the vascular wall and inflammatory processes occur at all 
stages of this disease [Ross 1986; Ross 1993; Ross 1999; Glass and Witztum 
2001; Steinberg 2002]. Chronic inflammation is a pathological hallmark of 
atherosclerosis [Ross 1986; Capron 1989; Ross 1993; Ross 1999], and 
inflammatory processes are involved at all stages of this disease [von der Thusen 
et al. 2003]. Fatty streak is the first morphological change in the development of 
atherosclerosis. The fatty streak is followed by the formation of an established 
plaque, which is characterised by the accumulation of macrophage foam cells and 
a local chronic inflammation. The problematical plaque is characterised by the 
formation of a fibrous cap. The production of degradative enzymes can then lead 
to a burst of the fibrous cap, which allows the  exposure of prothrombotic material 
leading to the formation of a thrombus through platelet aggregation [Stevens et al. 
2005], which causes clinical events such as heart attacks or strokes. 
Risk factors of atherosclerosis are high blood pressure, smoking, abdominal 
obesity, advanced age, male gender, diabetes, dyslipoproteinemia, high plasma 
homocysteine levels and in general an unhealthy pattern of life. Atherosclerosis is 
therefore the most common cause of illness and death in the western world. 
 
 
3.1.2. Atherosclerosis & Immunity  
 
Both, innate and adaptive immunity are involved in the pathogenesis of 
atherosclerosis. The communication between the innate and adaptive immune 
systems involves cell-cell interactions in relation to antigen presentation or 
proinflammatory and anti-inflammatory mediators such as cytokines or 
chemokines [Getz 2005]. IL-5 has recently been implicated in murine 
atherosclerosis. 
The best way to study the biological role of IL-5 in atherosclerosis was to generate 
an IL-5 knockout mouse.  IL-5 deficient mice were generated in the C57/BL6 
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background. Manfred Kopf and colleagues [Kopf et al. 1996] insert a neomycin 
resistance gene into the start of exon 3 in a codon for cysteine of the IL-5 gene 
which inhibited the dimerization and activity of IL-5 [Campbell et al. 1988; 
Takahashi et al. 1990]. IL-5 deficient mice had no observable signs of illness and 
were fertile [Kopf et al. 1996], but they have decreased numbers of eosinophils 
[Sferruzzi-Perri et al. 2003]. This mouse model is also particularly suitable to study 
the role of IL-5 in atherosclerosis. 
 
It has been shown that the anti-inflammatory cytokine IL-5 is expressed in human 
atherosclerotic lesions [Frostegard et al. 1999; Schonbeck et al. 2002] as well as 
in murine atherosclerotic lesions [Binder et al. 2004]. Furthermore, atherosclerotic 
lesions are significantly increased in IL-5-deficient LDLR-/- mice compared to 
LDLR-/- mice (Figure 5) [Binder et al. 2004] 
 
 
 
 
Figure 5: Increased atherosclerosis in IL-5–deficient LDLR–/– mice 
IL-5 secretion has also been shown to stimulate B-1 cells. B-1 cells are B cells that 
express the cluster of differentiation marker 5 (CD5), and express the pentameric 
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immunglobulin M (IgM) in greater quantities than monomeric Immunglobulin G 
(IgG). B-1 cells constitutively express membrane-anchored interleukin 5 receptor 
[Moon et al. 2004; Binder 2006]. IL-5 could play an indirect regulatory role by 
stimulation of B-1 cells to produce protective natural IgM antibodies (Figure 6). 
 
 
 
Figure 6: IL-5 links adaptive and innate immunity and activates an atheroprotective 
mechanism by secretion of natural IgM.  
 
3.2. Interleukins and their receptors 
 
Interleukins are a group of secreted immune system signaling molecules produced 
mainly, but not exclusively, by leukocytes. Interleukins initiate, mediate, and 
regulate immune responses and inflammatory reactions [Powrie and Coffman 
1993]. Interleukins or cytokines are involved in nearly each phase of immunity and 
inflammation. Usually they are not stored in specialized vesicles, but they are 
synthesized after cellular activation. One released cytokine can act on different cell 
types, which allows different biological effects also called pleiotropism. On the 
other hand, different interleukins have the same functional effect which refers to 
the redundant effect of interleukins. In most cases, the release of one cytokine 
leads to the synthesis and action of many other cytokines. Their action is initiated 
by binding to specific surface receptors on target cells. Functional properties of 
interleukins can be divided into three categories: (1) Mediators and initiators of 
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innate immunity, (2) Mediators and initiators of adaptive immunity and (3) 
stimulators of hematopoiesis [Abbas et al. 2003]. Further, these specialized 
signaling molecules can be divided into two groups: the proinflammatory and anti-
inflammatory cytokines. The proinflammatory property of cytokines results in their 
ability to produce tissue destruction and fever, whereas anti-inflammatory 
cytokines promote wound healing. 
 
 
3.2.1. Interleukin-5 
 
Interleukin-5 (IL-5) is a synonym of B-cell growth factor II, T-cell replacing factor, 
IgA enhancing factor and eosinophil differentiation factor [Takatsu et al. 1994]. 
IL-5 is mainly produced by activated TH2-cells which are a subpopulation of T-
cells. IL-5 plays a major role in differentiation of B-cells, in the recruitment, 
activation, persistence of eosinophils, and the production of immunoglobulin A 
(IgA) [Pazdrak et al. 1995]. Each cytokine binds to a specific cell-surface receptor. 
IL-5 interacts with the interleukin-5 Receptor. The binding leads to the activation of 
at least three different signaling pathways. First the activation of Ras Pathway and 
proto-oncogenes [Takaki et al. 1994], second the activation of Janus kinases 
(JAK) and Signal Transducer and Activator of Transcription (STAT) proteins 
[Weltman and Karim 2000] and third the activation of Bruton and Src-family 
tyrosine kinases [Sato et al. 1994]. IL-5 is crucially involved in many immunological 
processes and scientific publications about IL-5 are of substantial interest during 
the last 20 years in immunological research (Figure 7). 
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Figure 7: Scientific publications on Interleukin-5 found with NCBI search engine 
“Pubmed”. Pubmed search term: "IL-5" AND year[dp] 
 
 
3.2.2. The Interleukin-5 gene  
 
In humans, the IL-5 gene is located on chromosome 5q31 in a gene cluster 
together with IL-3, IL-4, IL-13 and granulocyte-macrophage colony stimulating 
factor (GM-CSF) [van Leeuwen et al. 1989]. In mice, the IL-5 gene is located on 
Chromosome 11 at location 29.2 cM [Lee et al. 1989]. The coding sequence of the 
murine and humane IL-5 gene consists of four exons. The mouse has a 738-base-
pair (Alu-like repeat inserted) in the 3-prime untranslated region (UTR), which 
leads to a difference in mRNA size between human and mouse. The size of the 
murine mRNA is 1.6 kilo bases (kb) whereas that of human mRNA is 0.9 kb 
(Figure 8). 
 
 
Figure 8: Schematic representation of the human (A) and murine (B) IL-5 gene. 
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 Several studies have shown that expression of the IL-5 gene is regulated at the 
transcriptional level. Upstream of the IL-5 coding sequence a TATA-like and a 
CAAT-like transcriptional initiation site are located and several other positive and 
negative regulatory elements have been identified [Le Beau et al. 1989; Wang et 
al. 1993; Gruart-Gouilleux et al. 1995; Yamagata et al. 1995; Zheng and Flavell 
1997].  
 
 
3.2.3.  Protein structure of Interleukin-5 
 
IL-5 is a glycoprotein with a molecular mass of 40-45 kDa and forms a disulfide 
linked homodimer. The human IL-5 protein comprises 134 and the murine protein 
133 amino acid residues, respectively and it includes a 19 amino acid signal 
peptide. Human and murine IL-5 proteins show 70 percent sequence homology 
which is dominantly located in the carboxyl-terminus (Figure 9). 
 
 
Figure 9: Alignment of the human and murine IL-5 amino acid sequence.  
Colors: RED represent small, hydrophobic including aromatic, blue acidic, 
magenta basic, green hydroxyl, amine and other amino acids are gray. Consensus 
sequence: "*" = identical or conserved residues in all sequences in the alignment; 
":" = indicates conserved substitutions; "." = indicates semi-conserved 
substitutions. Alignment was performed by Thomas Keller with ClustalW 1.83 
 
This high degree of similarity explains the immunological cross-reactivity observed 
between human and mice IL-5 [Campbell et al. 1988]. It has been shown that IL-5 
forms a cross-linked homodimer in an antiparallel arrangement (Figure 10) by a 
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disulfide bond between cysteine residues 44 and 86 [Minamitake et al. 1990; 
McKenzie et al. 1991; Milburn et al. 1993]. Reduction and alkylation of the two 
cysteins in recombinant hIL-5 or mutations in threonine residues lead to a 
biologically inactive monomer. The dimer formation via disulfide bonds is essential 
for the biological activity of IL-5. The variable, high molecular mass range 
observed for secreted IL-5 is explained by the heterogeneous addition of 
carbohydrates [Minamitake et al. 1990; Tominaga et al. 1990]. Mouse IL-5 (mIL-5) 
has an additional N-linked glycosylation at position Asn-55, which is not present in 
hIL-5 [Kodama et al. 1992]. 
  
 
Figure 10: Crystal structure at 2.4 angstroms resolution of human Interleukin-5.  
       Protein data bank ID: 1HUL 
 
 
3.2.4.  Biological function of Interleukin-5 
 
Haematopoiesis is the formation of blood cells. The hematopoietic system can be 
divided into three major different lineages, the erythroid, the myeloid and the 
lymphoid system, respectively (Figure 11) [Karlsson 2006]. The cells of the 
erythroid line are the red blood cells which fulfill the oxygen transport. 
Granulocytes, megakaryocytes and macrophages belong to the myeloid lineage. 
These cells are involved in innate immunity, adaptive immunity and blood clotting. 
The lymphoid lineage is mainly composed of B- and T-cells.  
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Figure 11: The hematopoietic system 
 
The major function of B-cells is to produce and secrete antibodies against 
exogenous antigens. Four different subsets of B-cells have been distinguished by 
their function. These are plasma B cells – the antibody producing cell of the 
immune system, Memory B cells which derive from activated B cells and B-1 and 
B-2 cells. B-1 cells express CD5 on their surface and more IgM than IgG. The 
conventional B-cells are B-2 cells. Further all B-cells express a B-cell specific 
receptor called B-cell receptor (BCR) [Berland and Wortis 2002; Abbas et al. 
2003]. 
 
The second important cell type of the lymphoid lineage is the T-cell. T-cells are 
produced in the thymus and play an important role in cell-mediated immunity of the 
adaptive immune system but do not recognize foreign antigens like B-cells. On the 
cell surface they express a specific receptor called the T cell receptor (TCR).  
 
Th cells differentiate into two major subsets - Th1 and Th2-cells. The two subsets 
differ in their cytokine production and the way how they stimulate the immune 
system. Th1-cells play a role in cell-mediated immunity, whereas Th2 cells provide 
help for B cells which is essential for antibody-mediated immunity.  
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In mice, B-1 cells (CD11b+ B-cells) isolated from the peritoneal cavity constitutively 
express the IL-5 Receptor complex and act in response to IL-5 to produce 
polyclonal IgM [Hitoshi et al. 1990; Rolink et al. 1990]. IgM is the first 
immunoglobulin expressed by mature B cells. The IgM antibody levels in serum 
are increased early during the course of an infection. Resting B-cells in spleen do 
not proliferate in response to IL-5, but IL-5 acts on certain activated B-cells to 
induce IgG1 and IgA production [Takatsu et al. 1994]. IL-5 induces proliferation, 
differentiation and maturation of eosinophilic precursors in bone marrow and 
expands the lifetime of eosinophils by delaying apoptotic death. IL-5 possesses 
eosinophil chemotactic activity, increases eosinophil adhesion to endothelial cells 
and enhances eosinophil effector functions [Clutterbuck et al. 1987; Yamaguchi et 
al. 1988; Yamaguchi et al. 1991; Sanderson 1992].  
 
In chronic asthma, an inflammation of the bronchi, eosinophils and CD4+ T-cells 
are involved [Robinson et al. 1992; Corrigan et al. 1993]. Both cell types are the 
major source of IL-5, and IL-5 levels increase during course of acute asthma 
[Alexander et al. 1994]. Increased IL-5 mRNA expression in atopic asthma is 
confirmed [Humbert et al. 1997]. IL-5 also has major role in atopic dermatitis, a 
chronic inflammatory disease of the skin [Leung et al. 2004].  
 
 
3.2.5. The Interleukin-5 Receptor  
 
IL-5 binds to a specific heteromeric receptor which is called interleukin-5 Receptor 
(IL-5R). Based on its sequence homology, the IL-5R is a member of the class I 
cytokine receptors (hematopoietin-like). The class I cytokine receptors can be 
further divided into three subfamilies: The GM-CSF receptor subfamily, Interleukin-
2 receptor subfamily and the Interleukin-6 receptor subfamily. The GM-CSF 
receptor subfamily contains the Receptors for GM-CSF, Interleukin-3 and 
Interleukin-5 (Figure 12) [Kuby 2006]. 
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Figure 12: GM-CSF receptor subfamily 
 
 
3.2.6.  Molecular constitution of interleukin-5 receptor 
 
The IL-5R complex is a heterodimer and consists of two polypeptide chains: an α-
chain and a β-chain (Figure 12). Both chains contain an extracellular domain, a 
transmembrane domain and an intracellular domain. Special key motifs as two 
cysteine pairs and the so-called WSXWS (Trp-Ser-Xaa-Trp-Ser; where Xaa is any 
amino acid) motif are characteristic for this receptor subfamily/receptor [Bazan 
1990]. The β-chain is shared between related receptors (IL-3, GM-CSF) in this 
subfamily and is denoted β-common (βc) subunit. The α subunit has specific 
ligand binding activity, whereas the βc subunit does not bind IL-5 by itself, but 
enhances the IL-5 binding. The intracellular domain of the βc subunit is essential 
for intracellular signal transduction [Takatsu et al. 1994]. The human IL-5 Receptor 
α (hIL-5Rα) gene is located on chromosome 3 in the region 3p26-p24 [Isobe et al. 
1992], and the mouse IL-5 Receptor α (mIL-5Rα) gene can be found on the long 
arm of chromosome 6 [Tuypens et al. 1992]. The human IL-5Rα gene is 
composed of 14 exons [Perez et al. 2003] and the murine IL-5Rα gene of 13 
exons, respectively (Figure 14) [Imamura et al. 1994; Bystrom et al. 2006].  
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The interleukin-5 receptor alpha precursor chain shows a high sequence 
homology between human and mice (Figure 13). 
 
 
 
Figure 13: Alignment of the human and murine IL-5 receptor alpha amino acid 
sequence. Colors: RED represent small, hydrophobic including aromatic, blue 
acidic, magenta basic, green hydroxyl, amine and other amino acids are gray. 
Consensus sequence: "*" = identical or conserved residues in all sequences in the 
alignment; ":" = indicates conserved substitutions; "." = indicates semi-conserved 
substitutions. Alignment was performed by Thomas Keller with ClustalW 1.83 
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Figure 14: Schematic representation of the human (A) and murine (B) IL-5Rα exon 
structure. S, signal peptide; EC, extracellular domain; M, transmembrane domain; 
C, cytoplasmic tail; (A)n, Polyadenylation sites [Tavernier et al. 2000; Bystrom et 
al. 2006]; 
 
Human and mouse βc subunit gene loci are located at chromosomes 22q12.3-
13.1 [Gorman et al. 1990; Shen et al. 1992].  
Through alternative splicing three different transcripts are produced from the same 
IL-5Rα locus. In addition to the membrane-anchored receptor, two soluble 
transcripts can be detected [Tuypens et al. 1992]. In humans, alternative splicing 
at exon 11 leads to the soluble isoforms, while exon 12 encodes the 
transmembrane domain (Figure 14A). Differential splicing of the murine IL-5Rα 
exons 11–13 result in the transmembrane (TM) and soluble isoforms 1 and 2 
(Figure 14B) [Bystrom et al. 2006]. 
These soluble receptor proteins can bind and neutralize secreted IL-5 by 
preventing interaction of the cytokine with the membrane-bound isoforms of the 
receptor α-chain [Kikuchi et al. 1994; Takatsu et al. 1994]. Only the membrane 
anchored form builds a complex with the common β-chain, which is required for 
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signalling. It also forms heterodimers with IL-3Rα and granulocyte-macrophage 
colony stimulating factor (GM-CSF) α-chain [Hara and Miyajima 1992] to build the 
IL-3 and GM-CSF receptors (Figure 12). 
 
 
3.2.7.  Interleukin-5 receptor signal transduction 
 
Ligand binding is the first event in IL-5R signal transduction. Binding of IL-5 leads 
to a dimerization of the ligand specific α-chain and the signal transducing βc-chain 
and to the activation of at least three different signaling pathways. IL-5 induces the 
activation of  1) Janus kinases (JAK) and Signal Transducer and Activator of 
Transcription (STAT) proteins [Weltman and Karim 2000], 2) Ras pathway and 
proto-oncogenes [Takaki et al. 1994], and 3) Bruton and Src-family tyrosine 
kinases (Figure 15).  
 
Figure 15: Interleukin-5 receptor signaling events. Binding of IL-5 to its specific 
receptor leads to the activation of at least three different signaling pathways 
[Meneki 2004] 
 
After dimerization of the IL-5R, the intracellular domain of the α-chain and ßc-chain 
is tyrosine phosphorylated by associated JAK1 and JAK2 proteins. JAK proteins 
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contain a kinase domain and a kinase-like domain, but they have no src homology 
2 or 3 domain (SH2, SH3). Members of this kinase family translate ligand binding 
to the membrane-anchored receptor with tyrosine phosphorylation of cellular 
proteins [Ihle 1995; Ihle 1995; Ihle and Kerr 1995]. Proteins which contain a SH2 
domain bind to phosphorylated tyrosine residues. STATs possess SH2 domains 
and bind to phosphotyrosines at the intracellular receptor domain [Wakioka et al. 
1999]. Further, JAK proteins phosphorylate STATs. This phosphorylation leads to 
the dimerization of STATs. In IL-5R signalling, especially STAT1 and STAT5 are 
involved. After dimerization, STAT proteins are activated and translocate from the 
cytoplasm to the nucleus and bind to specific DNA response elements in the 
promoter region of target genes to activate gene expression [Schindler 1999; 
Wakioka et al. 1999; Schindler et al. 2007].  
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4. Aim 
 
My thesis was based on the observation that mice fed a high fat diet exhibited a 
substantial rise of interleukin-5 levels in plasma . And that interleukin-5 has been 
shown to function as an anti-inflammatory, protective cytokine in murine 
atherosclerosis [Binder et al. 2004].  
Here, I hypothesized that interleukin-5 is prominently produced in the adipose 
tissue and that IL-5 expression is associated with obesity in mice.  
 
The overall aim of the present study was to study interleukin-5 expression in the 
white adipose tissue as surrogate for the metabolically important adipose tissue in 
C57BL/6 mice on normal vs. high fat diet. 
 
 
The key questions of my thesis were 
(1) To demonstrate expression of IL-5 in white adipose tissue 
(2) To unravel the exact cellular source of IL-5 in the adipose tissue  
(3) To provide insights into the potential role of IL-5 in the white adipose tissue. 
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5. Materials and Methods 
 
5.1. Antibodies and reagents  
 
Monoclonal Anti-human/mouse IL5 Antibody-TRFK5  
RnDSystems 
 
Biotinylated Anti-mouse IL-5 Antibody-TRFK4 
RnDSystems 
 
Recombinant Mouse IL-5 
RnDSystems; 
 
Avidin-Fluorescein Isothiocyanate (Av-FITC) 
BD Pharmingen; 
 
Rat Anti-IL-5 Monoclonal Antibody, FITC Conjugated, Clone TRFK5 
IMGENEX;  
 
Anti-Mouse F4/80 Biotin conjugated 
Caltag;  
 
CD11b/Mac-1 (CR3 
BD Pharmingen;  
 
Purified anti-mouse CD16/32 (Fc-Block) 
BD Pharmingen;  
 
Red blood cell lysis buffer (ACK-buffer): 
0.15 M NH4Cl, 10 mM KHC03, 0.1 mM Na2EDTA in distilled H20; pH 7-7.2 
 
 25 
Krebs-Ringer HEPES (1L) 
120 mM NaCl, 5mM KCl, 1,2 mM MgS04, 0,33 mM CaCl, 12 mM HEPES, 25 mM 
Glucose in distilled H20; pH 7.4 
MACS-Buffer  
2 mM EDTA, 0.5 % BSA in PBS 
 
FACS buffer 
2% BSA in PBS 
 
Bewer thioglycolate medium (3%) 
3% (w/v) Bewer thioglycolate medium is dissolved in H2O.  Afterwards the solution 
was boiled and autoclaved. Finally the solution should be stored for 6 month.  
 
 
5.2. Animals 
 
Homozygous IL-5-/- mice on C56BL/6 genetic background and wild type C57BL/6 
mice were kept under normal conditions at the animal facility at the Medical 
University of Vienna. Mice were obtained by heterozygous breeding of IL-5+/- 
mice. Figure 17 shows the genotype and gender distribution of 71 offspring’s. The 
animals were allowed free access to water and standard chow or high fat diet 
under a 12 h light/dark cycle. Mice were fasted for 2 hours before sacrifice by CO2 
inhalation. For mice earmarking system see supplemental material 10.4. 
 
For preparation of peritoneal exudate cells, 3ml of 3% Brewer thioglycollate media 
was injected into the peritoneal cavity. After 3 days, the mouse was sacrificed and 
peritoneal lavage with 10 ml 2%BSA/PBS was performed. The collected 
suspension contains the peritoneal exudate cells. Afterwards, the cells were 
washed 2 times with PBS and used for RNA isolation. 
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Figure 16: Mice breeding statistics of 71 mice. Heterozygous IL-5+/- mice on 
C56BL/6 genetic background was bred. 
 
 
5.3. Preparation of primary cell suspensions 
 
C57BL/6 mice were used for preparation of peritoneal exudates and splenocyte 
preparations. Peritoneal exudate cells (PEC) were isolated by peritoneal lavage 
with 10 ml ice-cold PBS (pH 7.4). For splenocyte preparations, spleens were 
removed after sacrifice by CO2 inhalation. The spleens were passed through a cell 
strainer  with 100 µm mesh size into a small culture plate (40mm x 10mm) using a 
sterile syringe plastic plunger to prepare a single-cell suspension. The mesh was 
rinsed twice with 2 ml PBS under sterile conditions. The cell suspension was then 
transferred into a new 15 ml falcon and kept on ice for 5 minutes to allow cell and 
connective tissue clumps settle on the bottom of the tube. Afterwards, the cell 
suspension in the supernatant was centrifuged at 300 g for 5 min at 4°C and  
washed with PBS followed by another step of centrifugation. Next, cells were 
resuspend in 5ml red blood cell lysis buffer (ACK-buffer:0.15 M NH4Cl, 10 mM 
KHC03, 0.1 mM Na2EDTA in distilled H20; pH 7-7,2) for 10min at room 
temperature. The cells were washed again with PBS and pelleted by centrifugation 
at 300 g for 5 min at 4°C. Finally, the pelleted splenocytes were resuspended in 
10ml RPMI 1640 cell culture medium, supplemented with 10% fetal bovine serum, 
50 µg/ml gentamycin and 2,5 µg/ml Fungizone. Cell viability was assessed with 
trypan blue exclusion. 
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5.4. Isolation of murine stromal vascular cell fraction and 
adipocytes of adipose tissue 
Gona L/6 mice fed normal chow or a 
igh fat diet were excised, and tissues were minced in a cell culture plate in PBS. 
etal bovine serum, 50 µg/ml gentamycin and 2,5 µg/ml fungizone 
5.5. Measurement of Interleukin-5 levels by ELISA 
bent assay 
LISA) in the supernatants of cultured stromal vascular cells. Either, with or 
 
dal white fat pads from male or female C57B
h
The minced tissue was then transferred into a 50 ml tube and digested 
enzymatically. Briefly, 30 µg/ml Liberase Blendzyme 3 (Roche) and 50 U/ml 
DNase I (Fermentas) in Krebs-Ringer HEPES buffer was added followed by 
incubation in a shaking water bath at 37°C for 60 min (at 150 rpm in a 45° angle). 
Every 20 minutes cells were pipetted up and down to dissociate the tissue. The 
resulting cell suspension was passed through a 100 µm mesh size filter to 
generate a uniform cell suspension and then centrifuged at 20 g for 5 min. 
Afterwards, the infranatant was collected and centrifuged again at 300g for 5 min 
and the rest, the adipocytes were used for RNA isolation and The pellet contained 
the stromal vascular cells (SVC). Next the SVC were washed 2 times with PBS 
and treated with red blood cell lysis buffer (ACK-buffer:0.15 M NH4Cl, 10 mM 
KHC03, 0.1 mM Na2EDTA in distilled H20; pH 7-7,2) for 5 min at room 
temperature to  destroy red blood cells. Finally, the SVCs were washed 2 times 
with PBS.  
SVCs were cultured in 6-well cell culture plates in 1 ml RPMI 1640  supplemented 
with 10% f
incubated at 37°C with 5% CO
2
.  
 
 
 
Levels of IL-5 were measured by sandwich enzyme-linked immunosor
(E
without 1µg/ml LPS stimulation. Microfluor 2 white U bottom 96-well microtiter 
plates were coated with 50 µl monoclonal anti-human/mouse IL-5 antibody (clone: 
TRFK5, class: rat IgG1; RnDSystems) in TBS  overnight at 4°C or 2 h at room 
temperature. Thereafter, wells were washed with PBS/EDTA to remove unbound 
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antibodies using an automated microplate washer (ELx405™, Bio-Tek), and wells 
were blocked with TBS containing 1%BSA for 30 minutes at room temperature. 
Plates were washed again, and 50 µl of cell culture supernatant or a dilution curve 
of recombinant IL-5 (Recombinant Mouse IL-5; RnDSystems) diluted in 
TBS/1%BSA were plated and incubated for 2 h at room temperature. Following 
another washing step, a biotinylated anti-mouse IL-5 (Clone TRFK4; RnDSystems) 
was added at a concentration of 150ng/ml for 1h at room temperature. Thereafter, 
plates were washed again and incubated with neutravidin alkaline phosphatase 
(AP) conjugate at room temperature for 1 hour.  A final washing step was 
performed with water, followed by the addition of 25 µl/well chemiluminescent 
substrate LumiPhos (Aureonbio) 1:3 diluted in water.  After 90 minute incubation at 
room temperature in darkness, plates were read using a chemiluminescent plate 
reader (Perkin Elmer Victor2). Values were retrieved as relative light units per 
100ms and the concentration of IL-5 was calculated on a standard curve 
constructed with serial dilutions of recombinant mouse IL-5. 
 
 
5.6. Protein quantification  
ts was determined using a commercially 
vailable kit, the “Bicinchoninic Acid (BCATM) Protein Assay Kit” from Pierce (UK). 
yi Biotec) was used to remove dead cells 
ccording to the manufacturer’s recommendations. 
CS) 
ell suspensions, 
agnetic bead cell sorting was employed. A stromal vascular cell suspension was 
 
The protein concentration of protein extrac
a
A bovine serum albumin (BSA) was used to generate a standard curve. 
 
5.7. Dead cell removal 
 
The Dead Cell Removal Kit (Milten
a
 
5.8. Magnetic bead cell sorting (MA
 
To separate macrophages from the remaining stromal vascular c
m
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prepared from murine white adipose tissue as described above. Cells were 
washed once in PBS and centrifuged at 300g for 5 min. The supernatant was 
removed and the cell pellet was resuspended in 500 µl degased MACS-Buffer (2 
mM EDTA, 0.5 % BSA in PBS). 5x105 cells were then incubated with 2.5 µg/ml 
purified anti-mouse CD16/CD32 (0.5 mg/ml; BD Pharmingen) diluted in MACS-
Buffer for 5 min at room temperature to block non-specific binding to Fcγ 
receptors. Subsequently, biotin-conjugated anti-mouse F4/80 antibodies were 
added a final concentration of 2 µg/ml to the cell suspension and incubated for 10 
min at RT. Then, cells were washed in 5 ml MACS-buffer, and the pellet was 
resuspended in 80 µl MACS-buffer and 20 µl (for up to 107 cells/ml) avidin-coupled 
MACS micro beads. After 15 min incubation at 4°C, cells were washed again. The 
supernatant was removed, and the pellet resuspended in 500 μl MACS-Buffer for 
magnetic separation. The cell suspension was applied onto a pre-washed MACS 
LS positive selection column, which was placed in the magnetic field of a MACS 
separator. The flow through was collected as the F4/80 negative fraction. 
Subsequently, the MACS column was removed from the magnetic field and F4/80 
positive cells were rinsed with 2 ml MACS buffer. Finally, the two cell fractions 
were washed and the cell viability was assessed by trypan blue exclusion. 
 
 
5.9. Flow-cytometry 
0 on stromal vascular cells was determined 
y flow cytometry. After isolation and separation as described above aliquots of 
 
Surface expression of CD11b and F4/8
b
5x105 cells were resuspended in 100 μl FACS buffer (2% BSA in PBS) in micronic 
tubes. The tubes were centrifuged at 300 x g for 5 minutes, and cell pellets were 
resuspended in 50 μl FACS buffer containing APC conjugated anti-mouse-CD11b 
antibody (BD Bioscience) at a dilution 1:2000 (0.2 mg/ml) or FITC conjugated anti-
mouse-F4/80 antibody (BD Bioscience) at a dilution 1:100 (0,1 µg/ml). After 30 
minutes of incubation at 4 °C in the dark, 1 ml FACS buffer was added to each 
sample for washing and cells were centrifuged at 300 x g for 5 minutes. The 
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resulting pellets were resuspended in 500 μl of FACS buffer and analyzed on an 
FACS Calibur Instrument (Becton Dickinson) using software FCS Express 2.0. 
 
 
5.10. Microscopy analyses 
5.10.1. Immunofluorescence 
Cells were washed in PBS and fixed in 100 µl of a 4% paraformaldehyde solution 
5.10.2. Haematoxylin & Eosin staining 
fter dissection, the white adipose tissue was rinsed three times with 1x PBS and 
fixed with 4% Paraformaldehyde or immediately frozen in liquid nitrogen. Stromal 
 
 
at 4°C for 10-20 min. After fixation cells were carefully washed in 1x PBS 
containing 0.1% saponin to permeabilize the cells.   Blocking was performed 20 
min at room temperature using a 1:5 dilution of goat serum. After blocking, cells 
were washed with PBS and then incubated with either FITC-conjugated anti-
mouse IL-5 monoclonal antibody (Clone TRFK5; IMGENEX) or Biotin-conjugated 
anti-mouse F4/80 (Caltag). The 1st antibody was diluted in 1xPBS containing 
0.1% saponin and incubated for 1h at room temperature. After incubation of the 
primary antibody cells were carefully washed three times with PBS. Afterwards, 
0.5 µg/ml of the 2nd antibody, Avidin-Fluorescein Isothiocyanate (Av-FITC) diluted 
in PBS was applied for 1h at room temperature. Then, cells were washed again 
three times. Nucleic staining was performed using DAPI diluted 1:200000 in PBS 
for 1min at room temperature. Cells were washed one more time with PBS, diluted 
in100µl PBS,  and spun onto glass slides at 400rpm using a cytospin centrifuge 
(Shandon centrifuge) for 2min , 5x10^4 cells (1x10^5 cells) in was performed. 
Finally, cover slips were mounted with “Vectra shield mounting medium”, and 
glass slides were stored at 2-8°C in the dark until analysis by fluorescent 
microscopy. Cells without staining (autofluorescence) and staining with 2nd 
antibody only were used as negative controls.  
 
 
A
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vascular cells were stained after cytospin at 800rpm for 1 min. On the next day 
Haematoxylin & Eosin (HE) was performed after sectioning of the fixed, frozen 
tissue with an automatic slide stainer at the Clinical Institute of Medical and 
Chemical Laboratory Diagnostics, Medical University of Vienna.   
 
5.10.3. Microscopy 
 
Immunofluorescence analysis was performed on an upright Zeiss Fluorescence 
icroscope (Axioskop 40FL).  Axio vision Software was used for data acquisition 
5.11. Nucleic acid methods 
nucleic acid concentrations 
easured with a photometer (Bio-Rad) at a wavelength of 260 nm and 280 nm. 
he ratio of OD260 nm versus OD280 nm describes the degree of purity of the 
ucleic acids. These should be ≥1.8 and should not exceed 2.0. Smaller ratios 
m
and analyses.  
 
 
 
5.11.1. Determination of 
 
To quantify the amount of DNA or RNA, the optical density of probes was 
m
For DNA (double strand) the OD260= 1 corresponds to a concentration of 50 
μg/ml, for RNA the OD260= 1 corresponds to a concentration of 40 μg/ml. These 
formulas were used to determine the DNA or RNA concentration of a sample. 
 
 
 
 
 
 
T
n
usually indicate contamination by protein remnants or organic compounds. 
 
 
   DNA: Unknown (μg/ml) = 50 μg/ml x measured A260 x dilution factor 
   RNA: Unknown (μg/ml) = 40 μg/ml x measured A260 x dilution factor 
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5.11.2. Genomic DNA preparation from mouse tissues 
ps. 
sing a DNeasy tissue kit (Qiagen) following the manufacturer´s instructions. 
5.11.3. Genotyping of mice 
rd PCR. PCR reaction mix (Table 1), 
rimers for IL-5 genotyping (Table 2) and PCR conditions for genotyping (Table 3) 
 
Mouse genomic DNA for genotyping was prepared from either tail or ear cli
U
 
 
 
Genotyping of mice was performed by standa
P
are listed below. 
 
1 Reaction  
[µl]
10x Buffer 2,5
MgCl2 [25mM] 2
dNTP [25mM] 0,25
s/α PrimerMix [10pmol 
each] 1
"Hot Start" Taq 0,125
Aqua bidestillata 18,125
MasterMix 24
DNA 1
Total 25  
Table 1: PCR reaction mix 
 
 
 
Table 2: Primers for IL-5 genotyping 
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1
2
3
4
5
6
Temperature 
[°C]
Time  
[mm:ss]
94 10:00
Cycles
denaturation 94 00:30 40annealing 60 00:30
cooling 4 ∞
lengthening 72 00:30
activation of hot start Taq
final lengthening 72 10:00
 
Table 3: PCR conditions for genotyping were 
 
The resulting fragm e and fragment of 
45bp a transgenic mouse. The insertion of a neomycin resistance gene results in 
ent of 228bp indicates an IL-5 wild type mous
3
the amplification of a bigger fragment in IL-5 deficient mice. A scheme of genomic 
situation is shown in Figure 16 and representative agarose gel electrophoresis of 
PCR products in Figure 17. 
 
 
 
Figure 17: Scheme of the disruption of the murine IL-5 gene. Figure taken from
opf et al. 1996] 
 
[K
 
 
 
Figure 18: Agarose gel electrophoresis for the detection of IL-5 genotype. 228bp 
IL-5 wild type and 345bp knock-out mouse; both fragments indicate heterozygote 
mice 1.5% agarose gel. 
 
 
5.11.4. Gel Electrophoresis 
 
Agarose gel preparation as well as electrophoresis buffer was prepared using Tris-
Acetate-EDTA (TAE) buffer solution (pH 8.0). 1.5 g agarose was added to 100 ml 
TAE to obtain a 1.5% w/v agarose gel. The PCR products were stained by 2 μl of 
6x loading buffer (Fermentas). Amplicons together with 100 bp DNA marker 
(Fermentas) were separated on the gels using 120 Volt and 100 mA for 45 min. To 
visualize the DNA fragments, 0.5 μg/ml ethidiumbromide was added to the liquid 
agarose. Ethidiumbromide intercalates into the stacked bases of the DNA 
molecule and emits light when illuminated with ultraviolet light. 
 
 
5.12. RNA techniques 
 
5.12.1. Isolation of total RNA from stromal vascular cells 
and mouse tissue 
 
Total RNA was isolated from the SVCs or from different organs using QIAGEN 
RNeasy mini spin columns according to the manufacturer’s recommendations. 
 35 
Cells were washed twice with PBS and lysed in 350 μl RNA lysis buffer. The lysate 
was mixed with equal volumes of 70 % ethanol and loaded onto the column. The 
column was spun at maximum speed for 15 seconds at RT. The column was then 
washed with RW1 (buffer provided by the manufacturer) and RPE (buffer provided 
by the manufacturer) buffer.RNA was eluted in 40 μl TE-buffer (QIAGEN) by 
centrifugation. RNA samples were stored at -80 °C. 
 
5.12.2. Isolation of total RNA from white adipose tissue 
and adipocytes 
 
The isolation of total RNA from white adipose tissue and adipocytes was 
performed with RNeasy Lipid Tissue Mini Kit from QIAGEN. For disruption and 
homogenization of the white adipose tissue a rotor-stator Ultra-Turrax 
homogenizer was used. In the presence of 1 ml QIAzol lysis Reagent (Qiagen) up 
to 1 g tissue was homogenized for 15 – 45 seconds. After 5 minutes at room 
temperature to permit the complete dissociation of nucleoprotein complexes, 200 
µl chloroform was added. Next the tube was mixed vigorously for 30 s to separate 
liquid and organic phase. The tubes were stored at room temperature for another 
5 min. The homogenate was centrifuged at 12,000 x g for 15 min at 4°C. During 
centrifugation, the sample separates into 3 phases: an upper, colorless, aqueous 
phase containing RNA; a white protein containing interphase; and a lower, red, 
organic phase. For tissues with an especially high fat content, an additional, clear 
phase may be visible below the red, organic phase. The volume of the aqueous 
phase should be approximately 600 µl. The upper phase was transferred into a 
fresh RNAse-free tube without disturbing the interphase. 600 µl of 70% ethanol 
was added and mixed thoroughly by vortexing. Afterwards, 600 µl of the sample 
including any precipitate that may have formed were transferred into an RNeasy 
Mini Spin Column (QIAGEN) in a 2 ml collection tube and centrifuged at 8000 x g 
for 15 s at room temperature. To wash the RNeasy Mini Spin Column 700 µl Buffer 
RW1 (buffer provided by the manufacturer) was added and centrifuged for 15 s at 
8000 x g. The washing procedure was repeated twice with Buffer RPE (buffer 
provided by the manufacturer). To elute the RNA, the RNeasy Mini Spin Column 
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was transferred to a new 1.5 ml collection tube. 40µl TE-buffer was added directly 
onto the RNeasy silica-gel membrane and centrifuge for 1 min at 10000 x g. RNA 
samples were stored at -80 °C until further analyses. RNA quality was assessed 
by UV spectroscopy. 
 
 
5.12.3. Reverse Transcription - cDNA synthesis 
 
For the synthesis of cDNA, total RNA was reversed transcribed using  the murine 
moloney leukemia virus reverse transcriptase (M-MLV RT) from Invitrogen™. In 
brief, 1 μg of total RNA was incubated with random hexamer primers at 70°C for 
10 min. Afterwards, 4 µl 5x first strand buffer, 2 µl dithiothreitol, 2 µl 
deoxyribonucleotide triphosphate [each 10mM], 0,5 µl ribonuclease Inhibitor 
(RNAsin) and 1µl M-MLV RT were added per reaction The  temperature protocol is 
shown in Table 4 
 
 
Table 4: RT-PCR temperature protocol 
 
 
5.13. Real Time PCR 
 
For quantitative assessment of specific mRNAs, real time PCR was performed.  
PCR product synthesis can be monitored by measuring the increase in 
fluorescence caused by the binding of the fluorescence dye SYBR Green. SYBR 
Green dye bind to double stranded DNA. Quantification of IL-5, IL-5Rα, F4/80, 
ACRP30, PPARγ, IL-10, MCP-1, LepR, HO-1, HPRT, CycB and Arp3 mRNA 
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expression was performed with the ABI Prism 7700 Sequence Detection System 
(Applied Biosystems) using SYBR Green I.  
 
 
Primer Sequence 5' - 3'
mIL-5_fwd GAG ACG ATG AGG CTT CCT GTC
mIL-5_rev TCCAATGCATAGCTGGTGATT
mIL-5R_fwd TTCAAGTGAGAGCAGCTGTGAGC
mIL5R_rev CACAATGAGATGCCATTCTACCCAG
mF480_fwd CTTTGGCTATGGGCTTCCAGTC
mF480_rev GCAAGGAGGACAGAGTTTATCGTG
mAcrp30_fwd GCTCCTGCTTTGGTCCCTCCAC
mAcrp30_rev GCCCTTCAGCTCCTGTCATTCC
mPPARγ_fwd GCATGGTGCCTTCGCTGA
mPPARγ_rev TGGCATCTCTGTGTCAACCATG
mIl10_fwd GCCAGAGCCACATGCTCCTA
mIl10_rev GTCCAGCTGGTCCTTTGTTTG
mMCP1_fwd AAGAGGATCACCAGCAGCAG
mMCP1_rev TCTGGACCCATTCCTTCTTG
mLepR_fwd CACATCTGCCGGTGTGAGTT
mLepR_rev GCAAACCTAAGGGTGGATCG
mHo1_fwd AGGTCAAGCACAGGGTGACA
mHo1_rev CATCACCTGCAGCTCCTCAA
mHprt_fwd CGCAGTCCCAGCGTCGTG
mHprt_rev CCATCTCCTTCATGACATCTCGAG
CycB_fwd CAGCAAGTTCCATCGTGTCATCAAGG
CycB_rev GGAAGCGCTCACCATAGATGCTC
mArp_fwd GCCAATAAGGTGCCAGCTGCTG
mArp_rev GAAGGAGGTCTTCTCGGGTCCTAG  
Table 5: Primers for real time PCR 
 
One reaction contained 10 µl iTaq™ SYBR Green Supermix with ROX, 0,5 µl 
forward and reverse primer mix [each 10mM], 7µl aqua bidest and 2,5 µl 1:5 
diluted reverse transcribed RNA. PCR conditions are shown in Table 5. 
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Table 6: Real time PCR temperature protocol 
 
 
After the last PCR cycle the melting curves for the amplification products were 
measured from 60°C to 95°C. The results were analysed with the SDS software 
v1.9.1 (Applied Biosystems) and the software “dissociation curve” to analyze the 
melting curve. The quantification of the PCR product is based on the calculation of 
the fluorescence threshold value (CT-value). The CT-value indicates the PCR-
cycle in which the reporter-fluorescence (SYBR green) surpasses the background-
fluorescence. After the CT-value is achieved the kinetics of the amplification 
reaction should be exponential. The CT-values of different templates can be 
compared among each other (relative quantification) or with a CT-value of a 
known template concentration (e.g. after cloning the target gene into a vector and 
transfections of cells) using a standard curve (absolute quantification). Raw data 
CT values above 35 were not used for calculation of the relative gene expression 
values, in all experiments. Here a relative quantification was performed. A Real-
Time PCR Thermal Cycler Model 7700 was used (Perkin Elmer ABI Prism). 
Analysis was performed with the Sequence Detection Software (SDS). 
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Figure 19: Screenshot of realtime quantification software. (A) increased 
fluorescence caused by the binding of the fluorescence dye SYBR Green during 
different PCR cycles. (Fluorescence as a function of time). (B) Control of the 
primer specificity by analysis of the melting temperature (Fluorescence as a 
function of temperature). 
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6. Results 
 
6.1. Interleukin-5 and Interleukin-5 Receptor α mRNA 
expression in different organs of mus musculus 
 
Different tissues where dissected from normally fed healthy C57BL/6 wild type 
mice to analyze IL-5 and IL-5Rα mRNA expression in these tissues. Twelve week 
old mice were used to obtain PEC, liver, kidney, thymus, the small intestine, white 
adipose tissue, and the spleen. After tissue homogenization, RNA was isolated, 
reverse transcribed into cDNA and analyzed by real time PCR for expression of IL-
5 and IL-5 Rα (Figure 20).  
 
 
 
Figure 20: Flowchart of the murine organ screen 
 
Thymus and spleen, which contain Il-5 expressing T-cells were used as positive 
control for IL-5 mRNA expression. In the case of IL-5Rα, peritoneal exudate cells 
(PEC) that are enriched in IL-5R expressing B-cells were used as positive control. 
 41 
Analysis of the real time PCR data (Figure 21) clearly showed expression of 
interleukin-5 and interleukin-5 receptor α mRNA in whole gonadal white adipose 
tissue from healthy C57BL/6 wild type mice fed regular chow. This indicated that 
WAT could be a source of IL-5, and was the first time that IL-5 mRNA expression 
was detected in white adipose tissue. 
 
Figure 21: Interleukin-5 (A) and Interleukin-5 receptor α (B) mRNA expression in 
different organs. PEC, peritoneal exudate cells. 3 mice, male. 
As expected, spleen and thymus displayed high IL-5 mRNA levels, whereas 
kidney, small intestine had moderate IL-5 mRNA expression.IL-5Rα mRNA was 
also found to be expressed in white adipose tissue, though at very low levels when 
compared to peritoneal exudate cells. Thus, white adipose tissue contains cells 
that express IL-5 (as well as the IL-5Ra). 
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6.2. Analysis of Interleukin-5 and Interleukin-5 Receptor α 
mRNA expression in different cell size fraction of the 
white adipose tissue  
 
After identifying IL-5 and IL-5Rα mRNA expression in the white adipose tissue, I 
asked which fraction dependent on the cell size expressed interleukin-5 and 
interleukin-5 receptor α, as WAT contains many different cell types, including 
mature adipocytes, macrophages, pre-adipocytes, stem cells, and endothelial 
cells. For this purpose I digested the dissected white adipose tissue to obtain the 
different cellular fractions. First, I passed the resulting single cell suspension 
through a 100µm mesh-size cell strainer to obtain the >100µm large cell fraction 
(large adipocytes). Next, the flow trough was passed again through a 30 µm mesh 
size cell strainer to obtain a <30µm large cell fraction. After centrifugation of the 
<30µm fraction, I could distinguish floating lipid containing cells (<30µm 
supernatant) and pelleted cells (<30µm pellet). The cells in the 30µm mesh-size 
cell strainer were collected as the 30µm-100µm fraction (small adipocytes).  
 
 
 
Figure 22: Interleukin-5 (A) and Interleukin-5 receptor α (B) mRNA expression in 
cell size dependent fractions. 2 mice, male. 
 
As shown in Figure 22, the <30µm pellet is the major IL-5 and IL-5Rα mRNA 
containing cellular fraction. This fraction, which is commonly denoted as stromal 
vascular cell fraction (SVC) is mostly composed of cells of the connective tissue, 
 43 
neuronal cells, microvascular endothelial cells, pluripotent stem cells and most 
importantly immune cells such as macrophages. After the first evidence of IL-5 
and IL-5Rα mRNA expression in the <30µm size pellet, I went on to validate these 
results by direct isolation of adipocytes and SVCs from the dissected white 
adipose tissue. The white adipose tissue was digested and separated (see 
material and methods 5.4) and respective realtime PCRs were performed.  
Analysis of the real time PCR data confirmed high levels of interleukin-5 mRNA 
expression in murine stromal vascular cells. In fact, compared to the whole WAT, 
IL-5 mRNA expression in the SVC fraction was enriched by the factor 12. 
Similarly, interleukin-5 receptor α mRNA expression was generally much higher in 
the SVC fraction than in the adipocyte fraction, though it was similar to the 
expression found in whole WAT (Figure 23). 
 
 
Figure 23: Interleukin-5 (A) and Interleukin-5 receptor α (B) mRNA expression in 
the white adipose tissue. 
 
 
6.3. Immunofluorescence microscopy of murine stromal 
vascular cells of the  white adipose tissue 
 
It is crucial to verify real-time PCR results of gene expression on the protein level. 
Fluorescent dye labeled specific antibodies can be used to visualize antigens and 
their cellular distribution by immunofluorescence microscopy. To identify IL-5 
expression by SVCs, I stained isolated SVCs with a fluorescently labeled antibody 
against mouse IL-5 and against F4/80, which is a macrophage marker.   
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Immunofluorescence microscopy of stromal vascular cells identified F4/80, IL-5 
(Figure 24).  
 
 
Figure 24: Immunofluorescence microscopy of stromal vascular cells 
 
 
Further, the shape of the nucleus of IL-5 single stained positive cells displayed a 
horseshoe like structure as it is common for macrophages. Immunofluorescence 
microscopy of murine stromal vascular cells of the gonadal white adipose tissue 
confirmed the real-time PCR results on the protein level. I could demonstrate that 
IL-5 protein is expressed by some cells of the SVC fraction of the WAT. 
 
 
 
6.4. In vitro culture of stromal vascular cells  
 
To confirm the production of IL-5 by stromal vascular cells, SVC were not only 
used for RNA isolation but were also propagated in cell culture (Figure 25). The 
SVC fraction consists of many different cell types, for example preadipocytes, 
macrophages and microvascular endothelial cells. Analysis of conventional light 
microscopy images demonstrates the heterogeneity of this cell fraction. 
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Figure 25: Bright field microscopy of primary cultured stromal vascular cells after 
18h.  
 
Among the viable cells, adherent cells as well as suspension cells were present 
after 18h in cell culture. A small amount of cells was dead, which were removed 
using a “dead cell removal kit” in further experiments to ensure a dead cell 
independent analysis. In this SVC fraction, adherent cells are typically considered 
to be macrophages. Macrophage accumulation is known to be associated with 
obesity and they represent a type of the stromal vascular cell fraction. Therefore, 
these cells were a chosen for further analysis. 
 
We also performed hematoxylin eosin (HE) staining of primary isolated murine 
stromal vascular cells to identify cell types (Figure 26). Immediately after digestion 
the cells were washed, counted and prepared for cytospin. The cytospin was done 
by 800rpm for 1 min. But it was not so easy to distinguish between different cells in 
HE stained stromal vascular cells.  
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Figure 26: HE staining of primary isolated murine stromal vascular cells 
immediately after digestion.  
 
 
6.5. Interleukin-5 protein level in cultured stromal vascular 
cells  
 
To study the capacity of cultured stromal vascular cells to secrete IL-5 in response 
to an inflammatory stimulus, SVCs of normal diet fed mice were isolated and equal 
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cell numbers were cultured for 48h with and without addition of LPS (1µg/ml).  IL-5 
levels were determined at several time points in the culture supernatants by 
sandwich ELISA (Figure 27).  
 
 
 
Figure 27: ELISA of Interleukin-5 protein levels in the supernatant of cultured 
stromal vascular cells at different time points 
 
Surprisingly, cultured SVCs displayed significant spontaneous secretion of IL-5 
even in the absence of any stimulus. In addition, LPS stimulation further increased 
IL-5 secretion in cultured stromal vascular cells. The level of IL-5 in the 
supernatant increased during the first 20h, whereas after 48h the secretion of IL-5 
in the supernatant did not significantly change in both conditions, respectively. 
Importantly, these results show that SVC are a source of IL-5 protein and that 
inflammatory stimuli, such as LPS, can  either directly or indirectly increase the IL-
5 production by cells of the SVC fraction. 
 
 
6.6. Effects of normal and high fat diet in C57BL/6 mice   
 
Recent evidence demonstrates that obesity is also associated with a chronic 
inflammatory response. To investigate the possibility that obesity is associated 
with changes in IL-5 mRNA expression in the adipose tissue, we induced a high 
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fat, high cholesterol diet to C57BL/6 mice. The mice were allowed free access to 
water and high fat, high cholesterol diet under a 12 h light/dark cycle and the 
control group were fed with standard chow. The administration of high fat, high 
cholesterol diet starts after weaning the mice which was usually 3 weeks after the 
mice were born. Male mice were killed at the age of 8 weeks. After sacrifice, the 
body weight of the mice and of the isolated white adipose tissue was determined 
(Figure 28). 
 
 
Figure 28: Body weight (A) and weight of the dissected white adipose tissue (B) of 
C57BL/6 wild type mice on normal (5 mice, male) and high fat diet (8 mice, male).  
 
While after 8-9 weeks of high fat diet the body weight was 33% compared to mice 
fed regular chow, the weight of the white adipose tissue increased by 700%. The 
body weight to white adipose tissue weight ratio is shown in Figure 29.  
 
Figure 29: Body weight and white adipose tissue ratio in 
C57BL/6. C57BL/6 wild type mice on normal (5 mice, male) and 
high fat diet (8 mice, male). 
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As expected the administration of high fat, high cholesterol diet lead to a 
significant increase of the body weight to white adipose tissue ratio compared to 
normal diet fed mice.  
 
 
6.7. HE staining of white adipose tissue from normal diet 
versus high fat diet fed C57BL/6 mice 
 
I also performed microscopic analysis to investigate morphological differences 
between white adipose tissue from normal diet versus high fat diet fed C57BL/6 
mice.  
 
 
 
Figure 30: HE staining of the white adipose tissue. (A, C) 10x, (B, D) 20x 
magnification; arrow indicate SVC.  
 
 
Consistent with previous reports [Weisberg et al. 2003], more SVCs in the white 
adipose tissue of high fat diet fed mice compared to normal diet fed mice (Figure 
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30) were found. Moreover, a marginally bigger adipocyte size in high fat diet fed 
mice was observed as well.  
 
 
6.8. IL-5 and IL5Rα expression in WAT of normal and high 
fat diet fed mice  
 
The expression of IL-5 and IL-5Rα mRNA expression in adipocytes and stromal 
vascular cells was analyzed by real time PCR (Figure 31). Male mice were 
sacrificed after 8 weeks on a high-fat diet at the age of 11-12 weeks. 
 
 
 
 
Figure 31: IL-5 mRNA expression in SVCs of normal (3 mice, male) and high fat 
diet (3 mice, male) fed mice (A). Comparison of the IL-5 mRNA expression in 
adipocytes and stromal vascular cells in high fat diet fed C57BL/6 mice (B).  
 
 
As shown for the WAT of conventional mice, IL-5 expression was primarily 
associated with the SVC fraction of obese mice (Figure 31B). Moreover, IL-5 
mRNA expression was significantly (p=0.0000026) increased in SVC of high fat 
diet administered mice compared to normal diet fed mice (Figure 31B), indicating 
an induction of IL-5 expression in response to high fat feeding and weight gain.  In 
contrast, IL-5Rα mRNA expression did not change significantly (not shown).  
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6.9. Separation of SVC into F4/80+ and F4/80- cells 
 
Because Weisberg and colleagues have shown that weight gain and obesity are 
associated with an increased macrophage infiltration of WAT, we aimed to isolate 
the macrophages of the SVC population and separated SVC into F4/80+ and 
F4/80- cell types (Figure 32A) to determine the exact cellular source of IL-5 in the 
SVC fraction. Magnetic activated cell sorting (MACS) was used for separation and 
the quality of this procedure was controlled by real time PCR by identification of 
F4/80 mRNA in the F4/80+ and in the flow through of MACS separation, the F4/80- 
cell population (Figure 32B).  
 
 
 
Figure 32: Schema of the separation of F4/80+ and F4/80- stromal vascular cells 
(A). F4/80 gene expression in F4/80+ and F4/80- MACS separated stromal 
vascular cells (B) derived from 4 mice. 
 
 
My separation protocol led to highly pure F4/80+ versus F4/80- cell populations. 
The F4/80 gene expression was enriched a 1,000-fold in the F4/80 positive 
compared to F4/80 negative fraction. Furthermore, this suggested that the gentle 
digestion procedure had no influence on F4/80 surface marker expression. This is 
important, because an intact F4/80 surface marker is necessary for magnetic 
beads mediated separation. 
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Upon cultivation of F4/80+ and F4/80- bead sorted SVC, we could distinguish two 
different main cell populations in the F4/80- cell fraction. Cultured F4/80- fraction 
contained adherent and non adherent cells (Figure 33).  
 
 
Figure 33: Bright field microscopy of stromal vascular cells. F4/80+ SVC fraction 
(A); F4/80- SVC fraction (B); F4/80- cells in suspension (C); F4/80- adherent cells 
(D); A-D:10x,18 h; 
 
 
Primary isolated SVCs were viable after 18h at cell culture conditions. 
Interestingly, the F4/80+ SVC fraction - mainly macrophages - did not adhere after 
18h in cell culture and formed cluster (Figure 33A). The F4/80- SVC fraction 
contained suspension cells (Figure 33B, C) and adherent cells (Figure 33B, D). 
Further, in the adherent F4/80- SVC fraction we observed cells with a round or a 
spindle shape structure.   So we could also identify cells in suspension cells and 
adherent cells in the F4/80- stromal vascular cell fraction, which likely represented 
fibroblasts. 
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The expression of the F4/80 antigen shifts during maturation and activation of 
macrophages. Another marker of macrophages is CD11b, which is also present on 
monocytes, NK cells and granulocytes. As additional quality control I analyzed the 
expression of CD11b in the F4/80+ versus F4/80- MACS sorted cell populations by 
flow cytometry (Figure 34). As expected, there was a clear enrichment of CD11b 
positive cells within the F4/80 positive fraction. 
 
 
 
Figure 34: FACS analysis of the F4/80+ and F4/80- magnetic bead separated 
stromal vascular cells (A, B) F4/80+ and (C, D) F4/80- cells. The procedure was 
performed with using a dead cell removal kit. 
 
However, only two-thirds of the F4/80+ cells were also CD11b+ (Figure 34A), 
suggesting differences in the cellular expression patterns between these two 
surface markers. 
 
Following the verification of the purity of the F4/80+ and F4/80- cell populations, I 
analyzed the IL-5 mRNA expression in both populations (Figure 35). As seen in 
Figure 36, there is a 2.5 fold enrichment of IL-5 expression in the F4/80+ cell 
population compared to total SVCs, which is not seen in the F4/80 – cell 
 54 
population. Thus, in obese high fat diet fed mice IL-5 expression in WAT is 
predominantly associated with tissue infiltrating F4/80+ macrophages 
 
 
 
Figure 35: IL-5 mRNA expression in F4/80+ and F4/80- MACS separated stromal 
vascular cells (2 mice, male) 
 
 
6.10. Cultured peritoneal macrophages of RAG deficient 
mice express Interleukin-5 in response to LPS 
 
To further verify that macrophages have the capacity to express IL-5 mRNA, I 
isolated peritoneal macrophages from RAG deficient mice. RAG is the 
abbreviation for recombination activating gene [Villa et al. 2001]. There are two 
mature RAG proteins (RAG1 and RAG2). Both RAG proteins are essential for 
immunoglobulin (Ig) and T-cell receptor gene recombination. Therefore, RAG 
deficient mice have no mature T- and B-cells. Thus, using RAG deficient mice as 
source of peritoneal macrophages excludes the major cellular source of IL-5, 
namely Th2 cells. Peritoneal macrophages were enriched by inducing an acute 
inflammation (peritonitis) through thioglycollate injection into the peritoneal cavity. 
Peritoneal macrophages were isolated, washed and cultured for 18h with and 
without LPS. After 18h the cells were lysed and the RNA was extracted for real 
time PCR analysis (Figure 36). 
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Figure 36: Thioglycollate elicited macrophages of RAG-/- mice express IL-5 in 
response to LPS 
 
Indeed, I could demonstrate that macrophages have the capacity to make IL-5 in 
response to an inflammatory stimulus. On the other hand IL-5Rα mRNA 
expression was not detectable (not shown). These results suggested that LPS 
induces IL-5 mRNA expression in peritoneal macrophages and that macrophages 
are able to secrete IL-5. 
 
 
 
6.11. Analysis of different genes in the stromal vascular cell 
population by real time PCR in IL-5 deficient and wt 
mice  
 
Following the demonstration that macrophages, i.e. peritoneal macrophages in 
response to LPS or WAT-infiltrating macrophages secrete IL-5, I hypothesized that 
IL-5 may modulate expression of important other genes in the WAT. Therefore, I 
also analyzed the mRNA expression of obesity and inflammation associated  
genes in wild type mice compared to IL-5 deficient mice (Figure 37).  
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Figure 37: mRNA expression in SVC in wild type vs. IL-5 deficient mice.4 wt and 6 
IL-5 deficient mice. 
 
Values, bigger than 1 indicate an elevated gene expression in wt mice. The 
expression of IL-5Rα, the Leptin Receptor (LepR), IL-10 and PPARγ was 
decreased in IL-5 deficient mice compared to wild type mice. 
Whereas adiponectin (ACRP30), Hemoxygenase-1 (HO-1) and MCP-1 is marginal 
up-regulated in IL-5 deficient mice. Interestingly, I did not observe any change in 
F4/80 mRNA expression. These data suggest that IL-5 may indeed influence 
expression of important genes in the WAT associated with obesity and the 
metabolic syndrome under physiological conditions (i.e. fed a regular chow). 
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7. Discussion 
 
First, the Interleukin-5 and Interleukin-5 receptor α mRNA expression in seven 
different organs of C57BL/6 mice was analysed by real time PCR and it was 
demonstrated that interleukin-5 and interleukin-5 receptor α mRNA is expressed in 
the gonadal white adipose tissue in C57Bl/6 mice for the first time (Figure 21).  
 
To verify these results, the white adipose tissue was digested and separated into 
two main fractions: adipocytes and stromal vascular cells. Interleukin-5 and 
interleukin-5 receptor α mRNA expression was clearly in the stromal vascular cell 
fraction (Figure 23). 
 
Moreover, immunofluorescence microscopy was used to demonstrate that the IL-5 
protein is expressed by some cells of the SVC fraction and not the adipocytes of 
the gonadal white adipose tissue (Figure 24). Interestingly, the shape of the 
nucleus of IL-5 positive cells is similar to macrophages. 
 
The stromal vascular fraction contains macrophages, and obesity is associated 
with an infiltration of macrophages [Weisberg et al. 2003].  
Based on this, I separated the SVC into F4/80+ and F4/80- cell types by MACS 
and identify F4/80+ cells of the stromal vascular cell fraction by real time PCR as 
the interleukin-5 positive fraction. F4/80 is a cell surface marker specific for 
macrophages.  
 
To confirm the production of IL-5 by stromal vascular cells, primary isolated murine 
stromal vascular cells were propagated in cell culture and were visualized by 
hematoxylin eosin (HE) staining (Figure 26). 
 
The supernatant of primary isolated cultured murine SVC were used for IL-5 
ELISA. The IL-5 level in the supernatant increased dramatically during the first 
20h. This result verifies that SVCs are able to secrete IL-5 and respond direct or 
indirect to LPS with an increased IL-5 production (Figure 27). In addition, I show 
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that thioglycollate elicited peritoneal macrophages of RAG deficient mice express 
IL-5 mRNA in response to LPS (Figure 36). 
 
Next, I investigated the possible changes on IL-5 mRNA expression in obese 
mice. For this purpose we induce obesity, by administration of a high fat, high 
cholesterol diet to C57BL/6 wild type mice. The diet significantly increased the 
body weight and especially the white adipose tissue weight.   
 
In this thesis, I could demonstrate that IL-5 but not IL-5R mRNA expression 
correlates with body weight and increases following feeding a high fat diet fed 
mice (Figure 31). HE staining of white adipose tissue from normal diet versus high 
fat diet fed C57BL/6 mice (Figure 30) was performed to investigate the diet 
induced enrichment of stromal vascular cells, especially macrophages. The 
infiltration of macrophages in the white adipose tissue was described by Weisberg 
et al. [Weisberg et al. 2003]. 
 
Finally, I analyzed the mRNA expression of metabolically important genes 
(e.g.MCP-1, LepR, PPARγ) in interleukin-5 deficient mice compared to wild type 
C57BL/6 mice. The differences in mRNA expression suggesting a protective role 
of interleukin-5 (Figure 37). 
 
The pathological hallmark of metabolic diseases like obesity is a chronic 
inflammation and further alterations of the metabolic activity or the secretion of 
soluble molecules like cytokines. Cytokines which were secreted by the adipose 
tissue are also called adipokines. Another important issue is the infiltration of 
macrophages which is increased in obesity [Weisberg et al. 2003]. Macrophages 
provide important immunological functions. 
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Based on my results, IL-5 may be added to the list of adipokines, potentially 
protective function, because several metabolically relevant genes are deregulated 
in interleukin-5 deficient mice. For example, monocyte chemoattractant protein-1 
(MCP-1) is decreased in IL-5 deficient mice. MCP-1 plays a role in the recruitment 
of monocytes which results in an accumulation of macrophages in the white 
adipose tissue. So, increased level of Interleukin-5 could prevent the infiltration of 
macrophages.  And this could lead to a decline of the chronic inflammation in the 
metabolic active white adipose tissue.   
 
Other metabolically active genes like peroxisome proliferator activated receptor γ 
(PPARγ) and leptin receptor are also decreased in IL-5 deficient mice. PPARγ is a 
member of the nuclear receptor family and play a major role in adipose tissue 
development, whereas leptin plays a important role in energy uptake and 
expenditure [Harris 2000; Rayner and Trayhurn 2001; Trayhurn and Beattie 2001]. 
The decrease of leptin receptor (LepR) in IL-5 deficient mice underlines the 
potential protective property of interleukin-5.  
 
Further evidence of a metabolically protective role of IL-5 comes from experiments 
performed by Koza and colleagues. They performed  DNA Microarray analysis of 
the white adipose tissue from C57BL/6J inbred mice with low and high weight gain  
[Koza et al. 2006].  Epididymal fat biopsies of 7 weeks old mice, before the high-fat 
diet and at the age of 15 weeks, after 8 weeks on a high-fat diet was analysed. 
Based on their weight gain following the high fat diet, individual mice were 
identified as low- and high-weight gainers for analysis, respectively. The analysis 
of the available microarray data showed differences in the expression of IL-5.  
 
Interestingly, high weight gainers displayed very low, whereas low gainers high IL-
5 expression (Figure 38). In other words, increased levels of IL-5 expression in 
mice prevents diet induced obesity in mice of the same genetic background. This 
microarray results corroborate our data and further indicate a protective role of 
interleukin-5. 
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Figure 38: IL-5 box plot in low and high gainer genetic identically C57BL/6 mice. 
Below red line Affymetrix signal absent above present [Koza et al. 2006] 
 
 
Obese mice have more interleukin-5 because the white adipose tissue contains 
more macrophages. On the other hand more macrophages secrete more 
interleukin-5 and should inhibit adipose tissue formation. In this context or 
physiological stage the highly metabolically white adipose tissue has a mechanism 
to prevent the increase of adipose tissue formation. However, the protective 
property of interleukin-5 is may only be relevant at early stages of obesity or 
adipose tissue development.  
 
In this respect it would be interesting to analyse the role of interleukin-5 in the 
white adipose tissue of ob/ob deficient mice, because these mice gain much more 
body weight than C57BL/6 mice on a high fat diet.  
 
In summary, the present study identifies stromal vascular cells derived 
macrophages (F4/80+ SVC) as source of interleukin-5 in the murine gonadal white 
adipose tissue. Furthermore, I could demonstrate that IL-5 mRNA expression in 
the stromal vascular fraction is increased in high fat diet compared to normal diet 
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fed C57BL/6 mice. Genetic deficiency of interleukin-5 results in differences in 
expression of metabolically important genes, suggesting a potentially protective 
function of interleukin-5. Interleukin-5 may be added to the list of adipokines. 
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10. Supplement 
 
10.1. mIL-5 Transcript sequence 
 
     1 CGCTCTTCCTTTGCTGAAGGCCAGCGCTGAAGACTTCAGAGTCATGAGAAGGATGCTTCT 
       ...........................................-M--R--R--M--L--L 
                                                                    
    61 GCACTTGAGTGTTCTGACTCTCAGCTGTGTCTGGGCCACTGCCATGGAGATTCCCATGAG 
     6 --H--L--S--V--L--T--L--S--C--V--W--A--T--A--M--E--I--P--M--S 
                                                                    
   121 CACAGTGGTGAAAGAGACCTTGACACAGCTGTCCGCTCACCGAGCTCTGTTGACAAGCAA 
    26 --T--V--V--K--E--T--L--T--Q--L--S--A--H--R--A--L--L--T--S--N 
                                                                    
   181 TGAGACGATGAGGCTTCCTGTCCCTACTCATAAAAATCACCAGCTATGCATTGGAGAAAT 
    46 --E--T--M--R--L--P--V--P--T--H--K--N--H--Q--L--C--I--G--E--I 
                                                                    
   241 CTTTCAGGGGCTAGACATACTGAAGAATCAAACTGTCCGTGGGGGTACTGTGGAAATGCT 
    66 --F--Q--G--L--D--I--L--K--N--Q--T--V--R--G--G--T--V--E--M--L 
                                                                    
   301 ATTCCAAAACCTGTCATTAATAAAGAAATACATTGACCGCCAAAAAGAGAAGTGTGGCGA 
    86 --F--Q--N--L--S--L--I--K--K--Y--I--D--R--Q--K--E--K--C--G--E 
                                                                    
   361 GGAGAGACGGAGGACGAGGCAGTTCCTGGATTACCTGCAAGAGTTCCTTGGTGTGATGAG 
   106 --E--R--R--R--T--R--Q--F--L--D--Y--L--Q--E--F--L--G--V--M--S 
          R                                       Y                 
   421 TACAGAGTGGGCAATGGAAGGCTGAGGCTGAGCTGCTCCATGGTGACAGGACTTCACAAT 
   126 --T--E--W--A--M--E--G--*-................................... 
                                   M                                
   481 TTAAGTTAAATTGTCAACAGATGCAAAAACCCCACAAAACTGTGCAAATGCAAGGGATAC 
       ............................................................ 
                        Y                                           
   541 CATATGCTGTTTCCATTTATATTTATGTCCTGTAGTCAGTTAAACCTATCTATGTCCATA 
       ............................................................ 
                                          M                         
   601 TATGCAAAGTGTTTAACCTTTTTGTATACGCATAAAAGAAATTCCTGTAGCGCAGGCTGG 
       ............................................................ 
                                                                    
   661 CCTCAAACTGGTAATGTAGCCAAGGATAACCTTGAATTTCTGATCCTCCTGCCTCCTCTT 
       ............................................................ 
                                                                    
   721 CCTGAAGGCTGAGGTTACAGACATGCACCATTGCCACTAGTTCATGAAGTGCTGGAGATG 
       ............................................................ 
                                                                    
   781 GAACCCAAGGCTTTGTGCATGTTACCAACTGAGTTATACTCCCTCCCCCTCATCCTCTTC 
       ............................................................ 
                                                                    
   841 GTTGCATCAGGGTCTCAAGTATTCCAGGCTGACTTTGAACTCAGTGTGTAGCCAAGGGTG 
       ............................................................ 
                                                                    
   901 ACCCTGAACTCTTGGTCCAGATGGACGCAGGAGGATCACATACCCAACCTTAGCATCCTT 
       ............................................................ 
                                                                    
   961 TCTCCTAGCCCCTTTAGATAGATGATACTTAATGACTCTCTTGCTGAGGGATGCCACACC 
       ............................................................ 
                                                                    
  1021 GGGGCTTCCTGCTCCTATCTAACTTCAATTTAATACCCACTAGTCAATCTCTCCTCAACT 
       ............................................................ 
                                                                    
  1081 CCCTGCTACTCTCCCCAAACTCTAGTAAGCCCACTTCTATTTCTTGGGGAGAGAGAAGGT 
       ............................................................ 
                                                                    
  1141 TGACTTTTCTTATGTCCTATGTATGAATCAGACTGTGCCATGACTGTGCCTCTGTGCCTG 
       ............................................................ 
                      K                                             
  1201 GAGCAGCTGGATTTTGGAAAAGAAAAGGGACATCTCCTTGCAGTGTGAATGAGAGCCAGC 
       ............................................................ 
                             YR                                R    
 66 
  1261 CACATGCTGGGCCTTACTTCTCCGTGTAACTGAACTTAAGAAGCAAAGTAAATACCACAA 
       ............................................................ 
                                    M                               
  1321 CCTTACTACCCCATGCCAACAGAAAGCATAAAATGGTTGGGATGTTATTCAGGTATCAGG 
       ............................................................ 
                                                K                   
  1381 GTCACTGGAGAAGCCTCCCCCAGTTTACTCCAGGAAAAACAGATGTATGCTTTTATTTAA 
       ............................................................ 
                                                                    
  1441 TTCTGTAAGATGTTCATATTATTTATGATGGATTCAGTAAGTTAATATTTATTACAACGT 
       ............................................................ 
                                          
  1501 ATATAATATTCTAATAAAGCAGAAGGGACAACTC 
       .................................. 
 
 
10.2. mIL-5Rα Transcript sequence 
 
                                    Y     S                       
     1 ATGGTGCCTGTGTTACTAATTCTTGTGGGAGCTTTGGCAACACTGCAAGCTGACTTACTT 
     1 -M--V--P--V--L--L--I--L--V--G-=A=-L-=A=-T--L--Q--A--D--L--L- 
                                                                    
    61 AATCACAAAAAGTTTTTACTTCTACCACCTGTCAATTTTACCATTAAAGCCACTGGATTA 
    21 -N--H--K--K--F--L--L--L--P--P--V--N--F--T--I--K--A--T--G--L- 
                                                                    
   121 GCTCAAGTTCTTTTACACTGGGACCCAAATCCTGACCAAGAGCAAAGGCATGTTGATCTA 
    41 -A--Q--V--L--L--H--W--D--P--N--P--D--Q--E--Q--R--H--V--D--L- 
                                                                    
   181 GAGTATCACGTGAAAATAAATGCCCCACAAGAAGACGAATATGATACCAGAAAGACTGAA 
    61 -E--Y--H--V--K--I--N--A--P--Q--E--D--E--Y--D--T--R--K--T--E- 
                                                                    
   241 AGCAAATGTGTGACCCCCCTTCATGAAGGCTTTGCAGCTAGCGTGAGGACCATTCTGAAG 
    81 -S--K--C--V--T--P--L--H--E--G--F--A--A--S--V--R--T--I--L--K- 
                                                                   
   301 AGCAGCCATACAACTCTGGCCAGCAGTTGGGTTTCTGCTGAACTCAAAGCTCCACCAGGA 
   101 -S--S--H--T--T--L--A--S--S--W--V--S--A--E--L--K--A--P--P--G- 
                     R                                              
   361 TCTCCTGGAACCTCGGTTACGAATTTAACTTGTACCACACACACTGTTGTAAGTAGCCAC 
   121 -S--P--G--T--S--V--T--N--L--T--C--T--T--H--T--V--V--S--S--H- 
                                                                   
   421 ACCCACTTAAGGCCATACCAAGTGTCCCTTCGTTGCACCTGGCTTGTTGGGAAGGATGCC 
   141 -T--H--L--R--P--Y--Q--V--S--L--R--C--T--W--L--V--G--K--D--A- 
                                                                    
   481 CCTGAGGACACACAGTATTTCCTATACTACAGGTTTGGTGTTTTGACTGAAAAATGCCAA 
   161 -P--E--D--T--Q--Y--F--L--Y--Y--R--F--G--V--L--T--E--K--C--Q- 
                                                                    
   541 GAATACAGCAGAGATGCACTGAACAGAAATACTGCATGCTGGTTTCCCAGGACATTTATC 
   181 -E--Y--S--R--D--A--L--N--R--N--T--A--C--W--F--P--R--T--F--I- 
                        R                                           
   601 AACAGCAAAGGGTTTGAGCAGCTTGCTGTGCACATTAATGGCTCAAGCAAGCGTGCTGCA 
   201 -N--S--K--G--F--E--Q--L--A--V--H--I--N--G--S--S--K--R--A--A- 
                                S                                   
   661 ATCAAGCCCTTTGATCAGCTGTTCAGTCCACTTGCCATTGACCAAGTGAATCCTCCAAGG 
   221 -I--K--P--F--D--Q--L--F-=S=-P--L--A--I--D--Q--V--N--P--P--R- 
                                                                    
   721 AATGTCACAGTGGAAATTGAAAGCAATTCTCTCTATATACAGTGGGAGAAACCACTTTCT 
   241 -N--V--T--V--E--I--E--S--N--S--L--Y--I--Q--W--E--K--P--L--S- 
                  Y                                                 
   781 GCCTTTCCAGATCATTGCTTTAACTATGAGCTGAAAATTTACAACACAAAAAATGGTCAC 
   261 -A--F--P--D--H--C--F--N--Y--E--L--K--I--Y--N--T--K--N--G--H- 
                                                                    
   841 ATTCAGAAGGAAAAACTGATCGCCAATAAGTTCATCTCAAAAATTGATGATGTTTCTACA 
   281 -I--Q--K--E--K--L--I--A--N--K--F--I--S--K--I--D--D--V--S--T- 
                                                                    
   901 TATTCCATTCAAGTGAGAGCAGCTGTGAGCTCACCTTGCAGAATGCCAGGAAGGTGGGGC 
   301 -Y--S--I--Q--V--R--A--A--V--S--S--P--C--R--M--P--G--R--W--G- 
                                                                    
   961 GAGTGGAGTCAACCTATTTATGTGGGAAAGGAAAGGAAGTCCTTGGTAGAATGGCATCTC 
   321 -E--W--S--Q--P--I--Y--V--G--K--E--R--K--S--L--V--E--W--H--L- 
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                        Y                                           
  1021 ATTGTGCTCCCAACAGCCGCCTGCTTCGTCTTGTTAATCTTCTCACTCATCTGCAGAGTG 
   341 -I--V--L--P--T--A--A--C--F--V--L--L--I--F--S--L--I--C--R--V- 
             Y                                                      
  1081 TGTCATCTATGGACCAGGTTGTTTCCACCGGTTCCGGCCCCAAAGAGTAACATCAAAGAT 
   361 -C--H--L--W--T--R--L--F--P--P--V--P--A--P--K--S--N--I--K--D- 
                                                       R            
  1141 CTCCCTGTGGTTACTGAATATGAGAAACCTTCGAATGAAACCAAAATTGAAGTTGTACAT 
   381 -L--P--V--V--T--E--Y--E--K--P--S--N--E--T--K--I-=E=-V--V--H- 
                                                        
  1201 TGTGTGGAAGAGGTTGGATTTGAAGTCATGGGAAATTCCACGTTTTGA 
   400 -C--V--E--E--V--G--F--E--V--M--G--N--S--T--F--*- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
http://www.ensembl.org/index.html 
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10.3. mouse cage card design 
 
 
 
10.4. Mice earmark system 
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